Suchergebnisse - (Person:"Spalluto, Giampiero")

PubPharm (182)

51

Exploring the directionality of 5-substitutions in a new series of 5-alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a strategy to design novel human a(3) adenosine receptor antagonists

enthalten in: Journal of medicinal chemistry | 2012

von Federico, S. | Ciancetta, A. | Sabbadin, D. | +6

52

Exploring the Directionality of 5-Substitutions in a New Series of 5-Alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a Strategy To Design Novel Human A3 Adenosine Receptor Antagonists.

enthalten in: Journal of medicinal chemistry | 2012

von Federico, S. | Ciancetta, A. | Sabbadin, D. | +6

53

Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry

enthalten in: Biochemical pharmacology | 2012

von Kozma, E. | Kumar, T. | Federico, S. | +7

54

Novel fluorescent antagonist as a molecular probe in A3 adenosine receptor binding assays using flow cytometry

enthalten in: Biochemical pharmacology | 2012

von Kozma, E. | Kumar, T. | Federico, S. | +7

55

Therapeutic potential of A2 and A3 adenosine receptor : a review of novel patented ligands

enthalten in: Expert opinion on therapeutic patents | 2012

von Federico, S. | Spalluto, G.

56

Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands

enthalten in: Expert opinion on therapeutic patents | 2012

von Federico, S. | Spalluto, G.

57

A novel conjugated agent between dopamine and an A2A adenosine receptor antagonist as a potential anti-Parkinson multitarget approach

enthalten in: Molecular pharmaceutics | 2012

von Dalpiaz, A. | Cacciari, B. | Vicentini, C. | +7

58

A Novel Conjugated Agent between Dopamine and an A2A Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach

enthalten in: Molecular pharmaceutics | 2012

von Dalpiaz, A. | Cacciari, B. | Vicentini, C. | +7

59

ChemInform Abstract: New 9‐Methyl‐8‐(4‐hydroxyphenyl)adenine Derivatives as A1 Adenosine Receptor Antagonists.

enthalten in: ChemInform | 2012

von Lambertucci, C. | Buccioni, M. | Cacciari, B. | +7

60

Does the combination of optimal substitutions at the C²-, N⁵- and N⁸-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A₃ adenosine receptors?

enthalten in: Bioorganic & medicinal chemistry | 2011

von Cheong, S. | Dolzhenko, A. | Paoletta, S. | +8